Related by context. Frequent words. (Click for all words.) 71 PEG PAL PEGylated recombinant 70 topical anti infective 69 phenylalanine ammonia lyase 69 transmucosal film 69 phenylketonuria PKU developed 69 pseudobulbar affect PBA 68 Onalta 67 Kuvan R 67 Medarex applies 67 gets USFDA nod 67 Meets Primary Endpoint 67 Panzem R 66 Fortical R 66 Excellagen 66 Inhalation Aerosol 66 R sorafenib tablets 66 topical gel 66 R bortezomib 66 active cellular immunotherapy 66 AzaSite Plus 66 MKC# 66 sublingual tablet 65 peripherally acting 65 Locteron ® 65 Emergent marketed 65 Hematide TM 65 VEGFR2 inhibitor 65 Panzem R NCD 65 voiding dysfunctions 65 2 methoxyestradiol 65 candidate Zenvia 65 6R BH4 65 Fibrillex TM 65 KRN# 65 Release Tablets 65 Excellarate 65 Application MAA 64 inflammatory autoimmune diseases 64 #-# rDNA origin 64 Advancing Drugs 64 injection USP 64 OMS#HP 64 topically delivered 64 TELINTRA 64 VALSTAR 64 Romidepsin 64 Ketotransdel 64 Initiates Phase II 64 Inhalation Solution 64 refractory chronic lymphocytic 64 Receives Orphan Drug Designation 64 Gabapentin GR 64 Lubiprostone 64 Soliris TM eculizumab 63 Phase Ib clinical trials 63 inhaled formulation 63 Anturol 63 malignant infectious 63 KNS # 63 opioid induced bowel dysfunction 63 inflammation autoimmune diseases 63 Peyronie Disease 63 candidates bavituximab 63 injectable formulation 63 urologic disease 63 chemotherapy induced neutropenia 63 TRANSDUR Sufentanil 63 Testim R 63 liposomal formulation 63 oropharyngeal candidiasis 62 PLK1 SNALP 62 fibrosis IPF 62 Injectable Suspension 62 Entereg R 62 relapsed multiple myeloma 62 Hypoactive Sexual Desire Disorder 62 SinuNase 62 dipropionate 62 Ferumoxytol 62 DAVANAT 62 Atrigel 62 postherpetic neuralgia PHN 62 Daclizumab 62 thymalfasin 62 Proxinium TM 62 oral candidiasis 62 Evamist TM 62 ALN TTR# 62 immuno inflammatory diseases 62 monobasic monohydrate USP 62 huC# DM4 62 opioid induced constipation OIC 62 Medipoints 62 GVAX R 62 factor VIIa 62 subcutaneous formulation 62 immunologic diseases 62 Factor VIIa 62 Topical Solution 62 PRT# 62 CEQ#